SavedAdd your journal

Journals / Ankara Medical Journal / 2012 / Cilt: 12 Sayı: 1

Special Virus Vaccines - 1

Özel Virüs Aşıları - 1

Selda SİVASLIOĞLU
Pages
42–45
Publication Date
2012-01-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There are vaccines for diseases that are not in current immunization schedules, but are frequently detected in public.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of immunization is to prevent the vaccine-prevantable disease especially in infants and children.
📊
Key Findings & Data:The aim of immunization is to prevent the vaccine-prevantable disease especially in infants and children.
💡
Conclusion & Impact:There are vaccines for diseases that are not in current immunization schedules, but are frequently detected in public.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Virüs aşıları · Rotavirüs · Hepatit A

Abstract

The aim of immunization is to prevent the vaccine-prevantable disease especially in infants and children. There are vaccines for diseases that are not in current immunization schedules, but are frequently detected in public.

Özet

Özet Bağışıklamada amaç; toplumda, özellikle bebek ve çocuklarda aşı ile korunabilir hastalıkların önüne geçmektir. Rutin aşı takvimimizde olmayan ancak toplumda sık gördüğümüz hastalıklara karşı virüs aşıları mevcuttur.

🔖

Cite This Article

SİVASLIOĞLU, S. (2012). Special Virus Vaccines - 1. Ankara Medical Journal, Cilt: 12 Sayı: 1, 42–45. https://ajindex.com/articles/981856

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. The Pink Book: Course Textbook - 12th Edition, chapter 8
  2. Prevention of Hepatitis A through active or passive immunization: Recommendations of Advisory Committee on Immunization Practices (ACIP).MMWR 2006; 55 (No. RR-7): 1-23
  3. Bell BP. Feinstone SM. Hepatitis A vaccine.In: Vaccines,Ed. By Plotkin SA, Orenstein WA,4th ed.Elsevier Inc.2004: 269-97. 4.
  4. Academy of Pediatrics.Hepatitis A. In: Pickering LK, Baker CJ, Long SS, McMillan JA,eds.Red Book:2006 Report of the Committee on Infectious Diseases.27th ed.Elk Grove Village, IL;American Academy of Pediatrics;2006: 326-35
  5. Galazka MA. Genel İmmünoloji. Bağışıklamanın İmmünolojik Temelleri içinde Çev:Egemen A., Akşit S.TC. Sağlık Bakanlığı TSH Genel Md. Yayınları. Ankara 1993:1- 20
  6. Gan R, Amir J, Livni G et al. Concomittant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial.Pediatr Infect Dis J. 2007; 26: 787-93
  7. Velazquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Eng J Med 1996; 405: 1022-8
  8. Clarck HF, Offit P, Glass RI, Ward RL. Rotavirus vaccines. In: Vaccines. Plotkin SA, Orenstein WA, (eds). 4th ed. Philadelphia, Saunders,2004:1327-1345 10. MP Manish, H Penina, Baggs J, et al. Intussusception and rotavirus vaccination: a review of the available evidence Expert Review of Vaccines, November 2009, Vol. 8, No. 11, Pages 1555-1564
  9. Palacios GR, Schael IP, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354: 11-22
  10. De Vos B, Vesikari T, Linhares AC,et al. A Rotavirus vaccine for Prophylaxis of Infants Against Rotavirus gastroenteritis Pediatr Infect Dis J 2004;23(10 suppl): S179-182.